Holen Sie sich die Stockscreener-App
75.19
6.77%
-5.46
Handel nachbörslich:
74.70
-0.49
-0.65%
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.13%
151.04
|
150.84 | 166.03 | 149.00 | 172.91 |
| Cost Of Revenue |
13.72%
38.54
|
44.66 | 52.98 | 48.70 | 47.82 |
| Gross Profit |
5.95%
112.50
|
106.18 | 113.05 | 100.31 | 125.08 |
| Operating Expenses |
7.16%
132.05
|
123.22 | 132.59 | 132.55 | 94.96 |
| Operating Income/Loss |
14.72%
-19.55
|
-17.05 | -19.54 | -32.24 | 30.13 |
| Nonoperating Income/Loss |
78.33%
0.91
|
4.199 | 4.348 | 4.037 | 6.871 |
| Income/Loss From Continuing Operations Before Tax |
45.13%
-18.64
|
-12.85 | -15.19 | -28.20 | 37.00 |
| Income Tax Expense/Benefit |
214.61%
-0.714
|
0.623 | 1.059 | -0.733 | 2.459 |
| Net Income/Loss |
33.12%
-17.93
|
-13.47 | -16.25 | -27.47 | 34.54 |
| Basic Average Shares |
1.32%
129.98
|
128.29 | 0.7847 | 125.50 | 123.76 |
| Diluted Average Shares |
1.32%
129.98
|
128.29 | 0.7847 | 125.50 | 124.51 |
| Basic Earnings Per Share |
40.00%
-0.14
|
-0.10 | -0.13 | -0.22 | 0.28 |
| Diluted Earnings Per Share |
40.00%
-0.14
|
-0.10 | -0.13 | -0.22 | 0.28 |
8.33%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):